Democratizing the Future of
Critical Facilities.
PodTech is transforming critical infrastructure through PODULE™ — pre-engineered, prefabricated and pre-validated modular facilities designed to accelerate delivery, simplify on-site execution and ensure quality.
Serving life sciences, semiconductors and advanced technology, PodTech delivers facilities in months, not years — built to scale with your ambitions.
Build smarter. Deliver faster. Scale without limits.
To move an industry forward, you need fresh thinking and bold doing.
Public health emergencies such as pandemics, highly contagious disease outbreaks, or geopolitical disruptions rarely come with a warning label. Governments and pharmaceutical companies must be prepared to respond swiftly, flexibly, and at scale, often under intense time pressure and operational constraints.
Podtech™ was developed to address this critical need. It is a cost-effective, time-efficient, start-to-finish modular solution for rapidly scalable biopharmaceutical development and manufacturing, enabling organizations to build, expand, or repurpose production capacity without the delays of conventional facilities.
Each Podtech™ unit comprises a configurable cluster of single or multiple podules™, engineered for reliability in demanding environments. Every podule™ is all-weather proof, seismically designed, and constructed using a reinforced steel structure with modular prefab architecture and industrial-grade vinyl flooring, ensuring durability, safety, and operational consistency.
Built entirely offsite, Podtech™ units are delivered fully assembled, prevalidated, and plug-and-play, significantly reducing on-site construction time, project risk, and disruption. Customizable configurations allow facilities to be tailored precisely to process, capacity, and regulatory requirements.
Whether supporting established pharmaceutical manufacturers scaling for specific programs or startups launching operations, Podtech™ enables rapid build, scale-up, and scale-out. Optional technology licensing and global manufacturing collaborations support accelerated go-to-market for applications such as fill-and-finish facilities, inhalation suites, oncology manufacturing, and novel therapeutic products.
Designed with repurposability and sustainability at its core, Podtech™ can be adapted to evolving use cases over time, helping organizations optimize capital investment, reduce environmental impact, and meet long-term sustainability and resilience goals efficiently.
Built to scale
Configurable podules™ that grow with your process, capacity, and ambitions.
Ready to perform
Built offsite, fully assembled, prevalidated, and delivered plug-and-play.
Designed for tomorrow
Repurposable, sustainable facilities that adapt as the world changes.
A more resilient world. A healthier everyone.
COVID-19 exposed the faultlines in our health systems and showed us how unprepared we are. Millions have died needlessly. Health systems continue to grapple with the continuing health impacts of Covid-19. The aftermath has proliferated a number of serious health conditions – brain fog, strokes, diabetes, kidney and heart disease – that are mini epidemics in themselves.
Wealthy countries can look after their own. Low and middle-income countries, reliant on medicine imports, are left to fend for themselves.
Stronger local production means more equitable access to lifesaving care.
With PodTech, governments and enterprising entrepreneurs alike can build your own path to regional self-sufficiency, especially in regions that have never had a seat at the table. You can better respond to public health emergencies.
A global vision.
A proven foundation.
Aasif Ahsan Khan
The vision behind PodTech™
PodTech™️ is the latest initiative from owner of the fabtech group Mr. Aasif Ahsan Khan. For over two decades, Fabtech has been one of the leading providers of start-to-finish solutions for biopharma companies across the world, from projects to essential equipment for air, water and process applications.
Podtech builds manufacturing capability all over the world – through pharmaceutical projects and an essential equipment manufacturing ecosystem for pharmaceutical and biopharmaceutical companies. Each new project we take on means we can reshape the world into a more equitable place for everyone.
